Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$2.1 million.

  • Standard Biotools' Other Non Operating Income fell 31859.98% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 7564.03%. This contributed to the annual value of $25.2 million for FY2024, which is 171258.09% up from last year.
  • Latest data reveals that Standard Biotools reported Other Non Operating Income of -$2.1 million as of Q3 2025, which was down 31859.98% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Other Non Operating Income ranged from a high of $25.2 million in Q1 2024 and a low of -$2.1 million during Q3 2025
  • Its 5-year average for Other Non Operating Income is $2.0 million, with a median of $363500.0 in 2021.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 124423.08% in 2022, then surged by 213123.89% in 2024.
  • Over the past 5 years, Standard Biotools' Other Non Operating Income (Quarter) stood at -$52000.0 in 2021, then tumbled by 1244.23% to -$699000.0 in 2022, then soared by 257.22% to $1.1 million in 2023, then decreased by 12.92% to $957000.0 in 2024, then plummeted by 318.6% to -$2.1 million in 2025.
  • Its Other Non Operating Income stands at -$2.1 million for Q3 2025, versus $5.0 million for Q2 2025 and $3.9 million for Q1 2025.